; (2) describes the activities undertaken by the State using the grant amounts; and (3) contains performance measures relating to the effectiveness of the grant, including changes in the participation rate of eligible collectors as authorized collectors. 3259. Duration of program The Attorney General may award covered grants for each of the first 5 fiscal years beginning after the date of enactment of this Act. 3260. Authorization of appropriations There is authorized to be appropriated to the Attorney General such sums as may be necessary to carry out this chapter. 7 Using Data To Prevent Opioid Diversion 3271. Short title This chapter may be cited as the Using Data To Prevent Opioid Diversion Act of 2018 . 3272. Purpose (a) In general The purpose of this chapter is to provide drug manufacturers and distributors with access to anonymized information through the Automated Reports and Consolidated Orders System to help drug manufacturers and distributors identify, report, and stop suspicious orders of opioids and reduce diversion rates. (b) Rule of construction Nothing in this chapter should be construed to absolve a drug manufacturer, drug distributor, or other Drug Enforcement Administration registrant from the responsibility of the manufacturer, distributor, or other registrant to— (1) identify, stop, and report suspicious orders; or (2) maintain effective controls against diversion in accordance with section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) or any successor law or associated regulation. 3273. Amendments (a) Records and reports of registrants Section 307 of the Controlled Substances Act ( 21 U.S.C. 827 ) is amended— (1) by redesignating subsections (f), (g), and (h) as subsections (g), (h), and (i), respectively